Fig. 4.

Answers to questions about porting program continuation. Q12: Have organ transplant surgeries in your hospital been stopped due to the COVID-19 pandemic? (a), Q13: What was the reason for the decision to suspend organ transplant surgeries? (Multiple answers allowed) (b), Q14: What kind of organ transplants were suspended? (c), Q16: What kind of organ transplants are being performed if transplant surgery is ongoing? (d). Response summaries: Q12: While no center discontinued its transplant surgeries for heart and lung transplants, one center (4%) suspended its transplant surgeries for liver transplants, 80 (78%) suspended their transplant surgeries for kidney transplants, and 4 (22%) suspended their transplant surgeries for pancreas transplants (a). Q13: The reasons for discontinuing transplantation were as follows: COVID-19-positive patients in the hospital (n = 12; 7%), COVID-19-positive patients in the prefecture (n = 26; 15%), in-hospital medical care system or examination system inadequate for assessing COVID-19 (n = 34; 19%), all surgical treatment (including transplantation) restricted (n = 33; 19%), and suspended in accordance with guidelines of the Japan Society for Transplantation (n = 57; 32%) (b). Q14: Fifty-six centers (31%) discontinued all transplants, including both deceased and living donor transplantation, 25 (14%) discontinued only living donor transplantation, and 1 (1%) discontinued only deceased donor transplantation (c). Q16: Of the centers with an ongoing transplant surgeries at the time of the questionnaire, 112 (63%) were providing transplant medical care without any specific restrictions, while 34 (19%) were limiting transplant surgery to cases when it was considered difficult to postpone (d)